letterNeurologyApr 27, 2004BRONZE OA

Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy [RETIRED]

Harvard University · Cornell University · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Objective

To assess the evidence demonstrating efficacy, tolerability, and safety of seven new antiepileptic drugs (AEDs) (gabapentin, lamotrigine, topiramate, tiagabine, oxcarbazepine, levetiracetam, and zonisamide-reviewed in the order in which these agents received approval by the US Food and Drug Administration) in the treatment of children and adults with newly diagnosed partial and generalized epilepsies.

Methods

A 23-member committee, including general neurologists, pediatric neurologists, epileptologists, and doctors in pharmacy, evaluated the available evidence based on a structured literature review including MEDLINE, Current Contents, and Cochrane library for relevant articles from 1987 until September 2002, with selected manual searches up until 2003.

No related works found for this paper.